| | | Incyte, Seattle Genetics Add Cash With Agreements (Update1) |  | Advertisements: |
|  12/21/09 Dec. 21 (Bloomberg) -- Incyte Corp. sold worldwide rights to an experimental pill being developed to treat inflammatory conditions to Eli Lilly & Co. , in a deal potentially worth more than $750 million. Incyte shares rose. READ FULL SOURCE |
Back to: Bothell WA news
Other news07/08/11 Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced results from a thorough QT (tQT) study that assessed the potential of exenatide to increase the QT interval across a wide range of plasma concentrations.
07/11/11 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced results from a thorough QT (tQT) study that assessed the potential of exenatide to increase the QT interval across a wide range of plasma concentrations.
07/13/11 The Zacks Analyst Blog Highlights: Alkermes, Amylin Pharmaceuticals, Eli Lilly and Company, Liberty Property Trust and Duke Realty Hot themes this week:
|
| |
| | HOT towns and cities: Northport, WA news • Mead, WA news • Newman Lake, WA news • Oak Harbor, WA news • South Hill, WA news • Dayton, WA news • Roy, WA news • East Side, WA news • Nine Mile Falls, WA news • Maple Valley, WA news • Bryant, WA news • North Seattle, WA news • Green Lake, WA news | |
|
(c) ProvinceCity.com - news and events from small towns, cities and megapolises.
All rights reserved. |
| |
Home Sitemap 0 news added |
|
|
